{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:43:06Z","timestamp":1790804586362,"version":"4.1.0"},"reference-count":196,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jaut.2017.05.004","type":"journal-article","created":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T19:01:05Z","timestamp":1494961265000},"page":"73-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"special_numbering":"C","title":["Unfolding the pathogenesis of scleroderma through genomics and epigenomics"],"prefix":"10.1016","volume":"83","author":[{"given":"Pei-Suen","family":"Tsou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr H.","family":"Sawalha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2017.05.004_bib1","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/rheumatology\/ker269","article-title":"Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies","volume":"51","author":"Elhai","year":"2012","journal-title":"Rheumatol. Oxf."},{"key":"10.1016\/j.jaut.2017.05.004_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/BOR.0b013e32834ff2e8","article-title":"Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers","volume":"24","author":"Barnes","year":"2012","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/BOR.0000000000000172","article-title":"Systemic sclerosis: a systematic review on therapeutic management from 2011 to 2014","volume":"27","author":"Young","year":"2015","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib4","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S","article-title":"Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts","volume":"44","author":"Arnett","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib5","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/art.11173","article-title":"Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies","volume":"48","author":"Feghali-Bostwick","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1586\/1744666X.2016.1125782","article-title":"An overview of environmental risk factors in systemic sclerosis","volume":"12","author":"De Martinis","year":"2016","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jaut.2017.05.004_bib7","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/ncprheum0435","article-title":"Mechanisms of Disease: environmental factors in the pathogenesis of rheumatic disease","volume":"3","author":"Gourley","year":"2007","journal-title":"Nat. Clin. Pract. Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13075-016-1127-6","article-title":"Familial risk of systemic sclerosis and co-aggregation of autoimmune diseases in affected families","volume":"18","author":"Kuo","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2017.05.004_bib9","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/art.22647","article-title":"Clinical, immunologic, and genetic features of familial systemic sclerosis","volume":"56","author":"Assassi","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jaut.2012.07.011","article-title":"Heritability versus the role of the environment in autoimmunity","volume":"39","author":"Selmi","year":"2012","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2017.05.004_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0049-0172(94)90096-5","article-title":"Twin studies in rheumatic diseases","volume":"24","author":"Jarvinen","year":"1994","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib12","first-page":"899","article-title":"Occurrence of rheumatoid arthritis in a nationwide series of twins","volume":"13","author":"Aho","year":"1986","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib13","first-page":"261","article-title":"Examinations of twins in multiple sclerosis","volume":"181","author":"Bammer","year":"1960","journal-title":"Dtsch. Z Nervenheilkd"},{"key":"10.1016\/j.jaut.2017.05.004_bib14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","article-title":"Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2017.05.004_bib15","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1002\/art.21355","article-title":"Monozygotic twins clinically discordant for scleroderma show concordance for fibroblast gene expression profiles","volume":"52","author":"Zhou","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib16","doi-asserted-by":"crossref","first-page":"e1002091","DOI":"10.1371\/journal.pgen.1002091","article-title":"Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis","volume":"7","author":"Allanore","year":"2011","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jaut.2017.05.004_bib17","doi-asserted-by":"crossref","first-page":"e1002178","DOI":"10.1371\/journal.pgen.1002178","article-title":"Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy","volume":"7","author":"Gorlova","year":"2011","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jaut.2017.05.004_bib18","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ng.565","article-title":"Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus","volume":"42","author":"Radstake","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2017.05.004_bib19","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/art.11220","article-title":"Genome-wide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalence","volume":"48","author":"Zhou","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib20","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1002\/art.24982","article-title":"HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans","volume":"60","author":"Zhou","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib21","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1093\/hmg\/ddt248","article-title":"A\u00a0systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci","volume":"22","author":"Martin","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jaut.2017.05.004_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ajhg.2013.12.002","article-title":"Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis","volume":"94","author":"Mayes","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jaut.2017.05.004_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.humimm.2016.10.017","article-title":"Genomic and genetic studies of systemic sclerosis: a systematic review","volume":"78","author":"Chairta","year":"2017","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jaut.2017.05.004_bib24","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/ard.2009.111906","article-title":"Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls","volume":"69","author":"Arnett","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.004_bib25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/rheumatology\/ker335","article-title":"Analysis of Class II human leucocyte antigens in Italian and Spanish systemic sclerosis","volume":"51","author":"Beretta","year":"2012","journal-title":"Rheumatol. Oxf."},{"key":"10.1016\/j.jaut.2017.05.004_bib26","doi-asserted-by":"crossref","first-page":"e0154255","DOI":"10.1371\/journal.pone.0154255","article-title":"Human leukocyte antigen and systemic sclerosis in Japanese: the sign of the four independent protective alleles, DRB1*13:02, DRB1*14:06, DQB1*03:01, and DPB1*02:01","volume":"11","author":"Furukawa","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2017.05.004_bib27","doi-asserted-by":"crossref","first-page":"e0126727","DOI":"10.1371\/journal.pone.0126727","article-title":"HLA class I and II blocks are associated to susceptibility, clinical subtypes and autoantibodies in Mexican systemic sclerosis (SSc) patients","volume":"10","author":"Rodriguez-Reyna","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2017.05.004_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/cei.12831","article-title":"Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis","volume":"186","author":"Ciccacci","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2017.05.004_bib29","doi-asserted-by":"crossref","first-page":"e111991","DOI":"10.1371\/journal.pone.0111991","article-title":"A\u00a0multilocus genetic study in a cohort of Italian SLE patients confirms the association with STAT4 gene and describes a new association with HCP5 gene","volume":"9","author":"Ciccacci","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2017.05.004_bib30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ng.2551","article-title":"Identification of multiple independent susceptibility loci in the HLA region in Behcet's disease","volume":"45","author":"Hughes","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2017.05.004_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.phrs.2016.04.010","article-title":"Notch in fibrosis and as a target of anti-fibrotic therapy","volume":"108","author":"Hu","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jaut.2017.05.004_bib32","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1242\/dev.004184","article-title":"Notch signaling in vascular development and physiology","volume":"134","author":"Gridley","year":"2007","journal-title":"Development"},{"key":"10.1016\/j.jaut.2017.05.004_bib33","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/s12891-016-1320-4","article-title":"Association of a rare NOTCH4 coding variant with systemic sclerosis: a family-based whole exome sequencing study","volume":"17","author":"Cardinale","year":"2016","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.jaut.2017.05.004_bib34","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1093\/hmg\/dds099","article-title":"Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up","volume":"21","author":"Martin","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jaut.2017.05.004_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2174\/1874312901408010043","article-title":"Lack of association of the CD247 SNP rs2056626 with systemic sclerosis in han Chinese","volume":"8","author":"Wang","year":"2014","journal-title":"Open Rheumatol. J."},{"key":"10.1016\/j.jaut.2017.05.004_bib36","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3389\/fimmu.2013.00266","article-title":"The role of type 1 interferon in systemic sclerosis","volume":"4","author":"Wu","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2017.05.004_bib37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/art.24183","article-title":"Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis","volume":"60","author":"Dieude","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib38","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/art.39730","article-title":"Brief report: IRF4 newly identified as a common susceptibility locus for systemic sclerosis and rheumatoid arthritis in a cross-disease meta-analysis of genome-wide association studies","volume":"68","author":"Lopez-Isac","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib39","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1002\/art.24885","article-title":"BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4","volume":"60","author":"Dieude","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib40","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/ard.2009.118174","article-title":"BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians","volume":"69","author":"Rueda","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.004_bib41","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/art.39721","article-title":"Brief report: whole-exome sequencing for identification of potential causal variants for diffuse cutaneous systemic sclerosis","volume":"68","author":"Mak","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaut.2009.08.014","article-title":"Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations","volume":"34","author":"Gourh","year":"2010","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2017.05.004_bib43","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/art.27303","article-title":"Association of the FAM167A-BLK region with systemic sclerosis","volume":"62","author":"Ito","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib44","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/art.30379","article-title":"C8orf13-BLK is a genetic risk locus for systemic sclerosis and has additive effects with BANK1: results from a large French cohort and meta-analysis","volume":"63","author":"Coustet","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib45","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nchembio.940","article-title":"Immunology: Csk keeps LYP on a leash","volume":"8","author":"Zhong","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jaut.2017.05.004_bib46","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nchembio.916","article-title":"LYP inhibits T cell activation when dissociated from CSK","volume":"8","author":"Vang","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jaut.2017.05.004_bib47","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1126\/science.1074900","article-title":"Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection","volume":"297","author":"Nguyen","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jaut.2017.05.004_bib48","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1002\/art.24688","article-title":"STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis","volume":"60","author":"Dieude","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib49","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1002\/art.24958","article-title":"Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1\/Th2 cytokines","volume":"60","author":"Gourh","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib50","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/hmg\/ddp119","article-title":"The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype","volume":"18","author":"Rueda","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jaut.2017.05.004_bib51","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/ard.2009.111310","article-title":"Association of STAT4 polymorphism with systemic sclerosis in a Japanese population","volume":"68","author":"Tsuchiya","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.004_bib52","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/s13075-014-0438-8","article-title":"An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3","volume":"16","author":"Zochling","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2017.05.004_bib53","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/ijd.12839","article-title":"Polymorphisms in STAT4 and IRF5 increase the risk of systemic sclerosis: a meta-analysis","volume":"55","author":"Xu","year":"2016","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib54","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/art.30171","article-title":"Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosis","volume":"63","author":"Avouac","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.2697","article-title":"Autophagy: cellular and molecular mechanisms","volume":"221","author":"Glick","year":"2010","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.jaut.2017.05.004_bib56","doi-asserted-by":"crossref","first-page":"e13778","DOI":"10.1371\/journal.pone.0013778","article-title":"PPARgamma downregulation by TGFss in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis","volume":"5","author":"Wei","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2017.05.004_bib57","doi-asserted-by":"crossref","first-page":"R6","DOI":"10.1186\/ar4432","article-title":"A\u00a0genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility","volume":"16","author":"Lopez-Isac","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2017.05.004_bib58","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13075-015-0641-2","article-title":"A\u00a0candidate gene study reveals association between a variant of the Peroxisome Proliferator-Activated Receptor Gamma (PPAR-gamma) gene and systemic sclerosis","volume":"17","author":"Marangoni","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2017.05.004_bib59","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/art.39449","article-title":"Identification of rare variants in ATP8B4 as a risk factor for systemic sclerosis by whole-exome sequencing","volume":"68","author":"Gao","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/art.40058","article-title":"Analysis of ATP8B4 F436L missense variant in a large Systemic sclerosis cohort","author":"Lopez-Isac","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib61","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/art.39476","article-title":"Identification of an association of TNFAIP3 polymorphisms with matrix metalloproteinase expression in fibroblasts in an integrative study of systemic sclerosis-associated genetic and environmental factors","volume":"68","author":"Wei","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib62","first-page":"18","article-title":"The epigenotype","volume":"1","author":"Waddington","year":"1942","journal-title":"Endeavour"},{"key":"10.1016\/j.jaut.2017.05.004_bib63","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/cbic.201000195","article-title":"Structure and function of mammalian DNA methyltransferases","volume":"12","author":"Jurkowska","year":"2011","journal-title":"Chembiochem Eur. J. Chem. Biol."},{"key":"10.1016\/j.jaut.2017.05.004_bib64","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.cell.2011.08.042","article-title":"DNA demethylation dynamics","volume":"146","author":"Bhutani","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2017.05.004_bib65","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.biochi.2012.05.016","article-title":"Mechanisms of DNA methylation and demethylation in mammals","volume":"94","author":"Auclair","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.jaut.2017.05.004_bib66","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1128\/MCB.18.11.6538","article-title":"Identification and characterization of a family of mammalian methyl-CpG binding proteins","volume":"18","author":"Hendrich","year":"1998","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jaut.2017.05.004_bib67","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1002\/pmic.201400013","article-title":"MBD5 and MBD6 interact with the human PR-DUB complex through their methyl-CpG-binding domain","volume":"14","author":"Baymaz","year":"2014","journal-title":"Proteomics"},{"key":"10.1016\/j.jaut.2017.05.004_bib68","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0168-9525(03)00080-5","article-title":"The methyl-CpG binding domain and the evolving role of DNA methylation in animals","volume":"19","author":"Hendrich","year":"2003","journal-title":"Trends Genet."},{"key":"10.1016\/j.jaut.2017.05.004_bib69","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1126\/science.1153252","article-title":"MeCP2, a key contributor to neurological disease, activates and represses transcription","volume":"320","author":"Chahrour","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.jaut.2017.05.004_bib70","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cmet.2010.09.004","article-title":"Histone methyl transferases and demethylases; can they link metabolism and transcription?","volume":"12","author":"Teperino","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.jaut.2017.05.004_bib71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbagrm.2008.06.005","article-title":"Chemical mechanisms of histone lysine and arginine modifications","volume":"1789","author":"Smith","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jaut.2017.05.004_bib72","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/nsmb.2436","article-title":"Perceiving the epigenetic landscape through histone readers","volume":"19","author":"Musselman","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jaut.2017.05.004_bib73","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/cr.2011.42","article-title":"Readers of histone modifications","volume":"21","author":"Yun","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.jaut.2017.05.004_bib74","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature08398","article-title":"Role of the polycomb protein EED in the propagation of repressive histone marks","volume":"461","author":"Margueron","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2017.05.004_bib75","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jaut.2017.05.004_bib76","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg2843","article-title":"The widespread regulation of microRNA biogenesis, function and decay","volume":"11","author":"Krol","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jaut.2017.05.004_bib77","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrg2521","article-title":"Long non-coding RNAs: insights into functions","volume":"10","author":"Mercer","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jaut.2017.05.004_bib78","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s00018-016-2174-5","article-title":"Mechanisms of long noncoding RNA function in development and disease","volume":"73","author":"Schmitz","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jaut.2017.05.004_bib79","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/03009740902758875","article-title":"Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis","volume":"38","author":"Lei","year":"2009","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib80","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/art.34376","article-title":"DNA demethylation of CD40l in CD4+ T cells from women with systemic sclerosis: a possible explanation for female susceptibility","volume":"64","author":"Lian","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib81","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.clim.2012.01.005","article-title":"Demethylation of TNFSF7 contributes to CD70 overexpression in CD4+ T cells from patients with systemic sclerosis","volume":"143","author":"Jiang","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2017.05.004_bib82","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1868-7083-6-25","article-title":"Hypomethylation and overexpression of ITGAL (CD11a) in CD4(+) T cells in systemic sclerosis","volume":"6","author":"Wang","year":"2014","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.jaut.2017.05.004_bib83","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/bjd.12913","article-title":"DNA hypermethylation of the forkhead box protein 3 (FOXP3) promoter in CD4+ T cells of patients with systemic sclerosis","volume":"171","author":"Wang","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib84","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000450949","article-title":"Disease manifestation and inflammatory activity as modulators of Th17\/Treg balance and RORC\/FoxP3 methylation in systemic sclerosis","volume":"171","author":"Almanzar","year":"2016","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.jaut.2017.05.004_bib85","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12929-015-0142-2","article-title":"DNA methylation similarities in genes of black South Africans with systemic lupus erythematosus and systemic sclerosis","volume":"22","author":"Matatiele","year":"2015","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.jaut.2017.05.004_bib86","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2249.2012.04621.x","article-title":"X\u00a0chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma","volume":"169","author":"Selmi","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2017.05.004_bib87","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/jcmm.12105","article-title":"Epigenetic repression of bone morphogenetic protein receptor II expression in scleroderma","volume":"17","author":"Wang","year":"2013","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.jaut.2017.05.004_bib88","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.gendis.2014.07.005","article-title":"Bone Morphogenetic Protein (BMP) signaling in development and human diseases","volume":"1","author":"Wang","year":"2014","journal-title":"Genes Dis."},{"key":"10.1016\/j.jaut.2017.05.004_bib89","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.21948","article-title":"Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts","volume":"54","author":"Wang","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib90","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1468-3083.2008.03016.x","article-title":"Predictors of the scleroderma phenotype in fibroblasts from systemic sclerosis patients","volume":"23","author":"Qi","year":"2009","journal-title":"J.\u00a0Eur. Acad. Dermatol. Venereol.: JEADV"},{"key":"10.1016\/j.jaut.2017.05.004_bib91","doi-asserted-by":"crossref","first-page":"25066","DOI":"10.1038\/srep25066","article-title":"IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics","volume":"6","author":"O'Reilly","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2017.05.004_bib92","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3892\/ijmm.2012.1150","article-title":"Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1","volume":"30","author":"Bujor","year":"2012","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jaut.2017.05.004_bib93","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1038\/ncomms6797","article-title":"Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis","volume":"5","author":"Noda","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2017.05.004_bib94","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1002\/art.34424","article-title":"Wnt\/\u03b2-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells","volume":"64","author":"Wei","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib95","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/ncomms1734","article-title":"Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis","volume":"3","author":"Akhmetshina","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2017.05.004_bib96","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/annrheumdis-2012-203194","article-title":"The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis","volume":"73","author":"Dees","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.004_bib97","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1136\/annrheumdis-2014-205303","article-title":"Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies","volume":"74","author":"Altorok","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.004_bib98","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/exd.12767","article-title":"Global DNA hypomethylation and hypoxia-induced expression of the ten eleven translocation (TET) family, TET1, in scleroderma fibroblasts","volume":"24","author":"Hattori","year":"2015","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib99","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1042\/CS20150697","article-title":"Epigenetic regulation of cyclooxygenase-2 by methylation of c8orf4 in pulmonary fibrosis","volume":"130","author":"Evans","year":"2016","journal-title":"Clin. Sci. Lond"},{"key":"10.1016\/j.jaut.2017.05.004_bib100","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clim.2013.06.006","article-title":"Aberrant histone modification in peripheral blood B cells from patients with systemic sclerosis","volume":"149","author":"Wang","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2017.05.004_bib101","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.clim.2015.03.006","article-title":"Overexpression of JMJD3 may contribute to demethylation of H3K27me3 in CD4+ T cells from patients with systemic sclerosis","volume":"161","author":"Wang","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2017.05.004_bib102","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1615\/CritRevOncog.2014012423","article-title":"Histone deacetylases and cancer-associated angiogenesis: current understanding of the biology and clinical perspectives","volume":"20","author":"Turtoi","year":"2015","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.jaut.2017.05.004_bib103","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1002\/art.39828","article-title":"Histone deacetylase 5 is overexpressed in scleroderma endothelial cells and impairs angiogenesis via repression of proangiogenic factors","volume":"68","author":"Tsou","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib104","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1073\/pnas.0400782101","article-title":"A\u00a0gene atlas of the mouse and human protein-encoding transcriptomes","volume":"101","author":"Su","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2017.05.004_bib105","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/HYPERTENSIONAHA.112.191098","article-title":"Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells","volume":"60","author":"Dreger","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.jaut.2017.05.004_bib106","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10456-015-9485-2","article-title":"The decrease in histone methyltransferase EZH2 in response to fluid shear stress alters endothelial gene expression and promotes quiescence","volume":"19","author":"Maleszewska","year":"2016","journal-title":"Angiogenesis"},{"key":"10.1016\/j.jaut.2017.05.004_bib107","first-page":"1091","article-title":"EZH2 modulates angiogenesis and fibrosis in scleroderma","volume":"68","author":"Tsou","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib108","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/art.24494","article-title":"Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis","volume":"60","author":"Hemmatazad","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib109","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1002\/art.22759","article-title":"Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis","volume":"56","author":"Huber","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib110","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/annrheumdis-2012-201615","article-title":"Inhibition of H3K27 histone trimethylation activates fibroblasts and induces fibrosis","volume":"72","author":"Kramer","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.004_bib111","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/jcp.21162","article-title":"The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis","volume":"213","author":"Ghosh","year":"2007","journal-title":"J.\u00a0Cell Physiol."},{"key":"10.1016\/j.jaut.2017.05.004_bib112","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/art.20996","article-title":"Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta","volume":"52","author":"Bhattacharyya","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib113","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/jid.2012.479","article-title":"p300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-beta: epigenetic feed-forward amplification of fibrosis","volume":"133","author":"Ghosh","year":"2013","journal-title":"J.\u00a0Investig. Dermatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib114","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/art.39061","article-title":"The histone deacetylase sirtuin 1 is reduced in systemic sclerosis and abrogates fibrotic responses by targeting transforming growth factor beta signaling","volume":"67","author":"Wei","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib115","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/annrheumdis-2014-205740","article-title":"Sirt1 regulates canonical TGF-\u03b2 signalling to control fibroblast activation and tissue fibrosis","volume":"75","author":"Zerr","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.004_bib116","doi-asserted-by":"crossref","first-page":"8340","DOI":"10.1074\/jbc.M109.088682","article-title":"SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1","volume":"285","author":"Pacholec","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jaut.2017.05.004_bib117","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1747-0285.2009.00901.x","article-title":"Resveratrol is not a direct activator of SIRT1 enzyme activity","volume":"74","author":"Beher","year":"2009","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jaut.2017.05.004_bib118","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nm.3777","article-title":"Orphan nuclear receptor NR4A1 regulates transforming growth factor-beta signaling and fibrosis","volume":"21","author":"Palumbo-Zerr","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2017.05.004_bib119","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004592","article-title":"Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis","volume":"7","author":"Svegliati","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jaut.2017.05.004_bib120","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/art.27443","article-title":"MicroRNA-29, a key regulator of collagen expression in systemic sclerosis","volume":"62","author":"Maurer","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib121","doi-asserted-by":"crossref","first-page":"e111266","DOI":"10.1371\/journal.pone.0111266","article-title":"MiR-30a-3p negatively regulates BAFF synthesis in systemic sclerosis and rheumatoid arthritis fibroblasts","volume":"9","author":"Alsaleh","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2017.05.004_bib122","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.4049\/jimmunol.1100591","article-title":"Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts","volume":"188","author":"Nakashima","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.05.004_bib123","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/annrheumdis-2014-205326","article-title":"Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression","volume":"75","author":"Iwamoto","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.004_bib124","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1002\/art.20562","article-title":"Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis","volume":"50","author":"D'Alessio","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib125","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1002\/art.22263","volume":"54","author":"Margheri","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib126","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1136\/annrheumdis-2013-203706","article-title":"Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?","volume":"73","author":"Manetti","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.004_bib127","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ajpath.2012.09.023","article-title":"miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin beta3","volume":"182","author":"Honda","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2017.05.004_bib128","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s10875-011-9647-y","article-title":"MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma","volume":"32","author":"Zhu","year":"2012","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.jaut.2017.05.004_bib129","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s10875-013-9896-z","article-title":"MicroRNA-21 in scleroderma fibrosis and its function in TGF-beta-regulated fibrosis-related genes expression","volume":"33","author":"Zhu","year":"2013","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.jaut.2017.05.004_bib130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00296-010-1615-y","article-title":"MicroRNA array analysis of microRNAs related to systemic scleroderma","volume":"32","author":"Li","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2017.05.004_bib131","doi-asserted-by":"crossref","first-page":"e115596","DOI":"10.1371\/journal.pone.0115596","article-title":"MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-beta activated kinase 1 binding protein 1, implications for systemic sclerosis","volume":"9","author":"Ciechomska","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2017.05.004_bib132","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.4049\/jimmunol.1100876","article-title":"TGF-beta-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts","volume":"188","author":"Honda","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.05.004_bib133","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.4049\/jimmunol.1200822","article-title":"The downregulation of microRNA let-7a contributes to the excessive expression of type I collagen in systemic and localized scleroderma","volume":"190","author":"Makino","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.05.004_bib134","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/exd.12900","article-title":"Long non-coding RNA TSIX is upregulated in scleroderma dermal fibroblasts and controls collagen mRNA stabilization","volume":"25","author":"Wang","year":"2016","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib135","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.biopha.2016.12.080","article-title":"MicroRNA-202-3p regulates scleroderma fibrosis by targeting matrix metalloproteinase 1","volume":"87","author":"Zhou","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jaut.2017.05.004_bib136","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/jid.2012.252","article-title":"Discoidin domain receptor 2-microRNA 196a-mediated negative feedback against excess type I collagen expression is impaired in scleroderma dermal fibroblasts","volume":"133","author":"Makino","year":"2013","journal-title":"J.\u00a0Investig. Dermatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib137","doi-asserted-by":"crossref","first-page":"20314","DOI":"10.1038\/srep20314","article-title":"Targeting miR-155 to treat experimental scleroderma","volume":"6","author":"Yan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2017.05.004_bib138","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3109\/14397595.2014.1001311","article-title":"MicroRNA-130b regulates scleroderma fibrosis by targeting peroxisome proliferator-activated receptor gamma","volume":"25","author":"Luo","year":"2015","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib139","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajpath.2012.09.007","article-title":"Toll-like receptor 4 signaling augments transforming growth factor-beta responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma","volume":"182","author":"Bhattacharyya","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2017.05.004_bib140","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ajpath.2011.10.030","article-title":"Increased accumulation of extracellular thrombospondin-2 due to low degradation activity stimulates type I collagen expression in scleroderma fibroblasts","volume":"180","author":"Kajihara","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2017.05.004_bib141","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00403-012-1287-4","article-title":"microRNA-7 down-regulation mediates excessive collagen expression in localized scleroderma","volume":"305","author":"Etoh","year":"2013","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.jaut.2017.05.004_bib142","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1093\/nar\/gkr254","article-title":"Characterization of extracellular circulating microRNA","volume":"39","author":"Turchinovich","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jaut.2017.05.004_bib143","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1373\/clinchem.2010.147405","article-title":"The microRNA spectrum in 12 body fluids","volume":"56","author":"Weber","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jaut.2017.05.004_bib144","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jdermsci.2010.11.007","article-title":"Circulating miR-29a levels in patients with scleroderma spectrum disorder","volume":"61","author":"Kawashita","year":"2011","journal-title":"J.\u00a0Dermatol. Sci."},{"key":"10.1016\/j.jaut.2017.05.004_bib145","first-page":"1171","article-title":"Major clinical diagnoses found among patients with Raynaud phenomenon from the general population","volume":"17","author":"Maricq","year":"1990","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib146","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF00372068","article-title":"Clinical evaluation of scleroderma spectrum disorders using a points system","volume":"284","author":"Ihn","year":"1992","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.jaut.2017.05.004_bib147","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2230.2011.04158.x","article-title":"Circulating miR-142-3p levels in patients with systemic sclerosis","volume":"37","author":"Makino","year":"2012","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib148","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/rheumatology\/kes120","article-title":"microRNA-92a expression in the sera and dermal fibroblasts increases in patients with scleroderma","volume":"51","author":"Sing","year":"2012","journal-title":"Rheumatol. Oxf."},{"key":"10.1016\/j.jaut.2017.05.004_bib149","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3899\/jrheum.140502","article-title":"The circulating cell-free microRNA profile in systemic sclerosis is distinct from both healthy controls and systemic lupus erythematosus","volume":"42","author":"Steen","year":"2015","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib150","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/rheumatology\/ket254","article-title":"Alteration of circulating miRNAs in SSc: miR-30b regulates the expression of PDGF receptor beta","volume":"52","author":"Tanaka","year":"2013","journal-title":"Rheumatol. Oxf."},{"key":"10.1016\/j.jaut.2017.05.004_bib151","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1684\/ejd.2014.2384","article-title":"Down-regulation of microRNA-196a in the sera and involved skin of localized scleroderma patients","volume":"24","author":"Makino","year":"2014","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib152","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/exd.12173","article-title":"Expression analysis of multiple microRNAs in each patient with scleroderma","volume":"22","author":"Koba","year":"2013","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib153","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1093\/rheumatology\/kev234","article-title":"Specific autoantibody profiles and disease subgroups correlate with circulating micro-RNA in systemic sclerosis","volume":"54","author":"Wuttge","year":"2015","journal-title":"Rheumatol. Oxf."},{"key":"10.1016\/j.jaut.2017.05.004_bib154","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.gpb.2015.02.001","article-title":"Exosome and exosomal MicroRNA: trafficking, sorting, and function","volume":"13","author":"Zhang","year":"2015","journal-title":"Genom. Proteom. Bioinforma."},{"key":"10.1016\/j.jaut.2017.05.004_bib155","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jdermsci.2016.06.013","article-title":"Altered expression of CD63 and exosomes in scleroderma dermal fibroblasts","volume":"84","author":"Nakamura","year":"2016","journal-title":"J.\u00a0Dermatol. Sci."},{"key":"10.1016\/j.jaut.2017.05.004_bib156","article-title":"Exosomes isolated from serum of systemic sclerosis patients display alterations in their content of profibrotic and antifibrotic microRNA and induce a profibrotic phenotype in cultured normal dermal fibroblasts","author":"Wermuth","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib157","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijcard.2016.01.129","article-title":"Avoiding heparin inhibition in circulating MicroRNAs amplification","volume":"207","author":"Li","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jaut.2017.05.004_bib158","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1158\/1940-6207.CAPR-11-0370","article-title":"Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies","volume":"5","author":"Pritchard","year":"2012","journal-title":"Cancer Prev. Res. Phila"},{"key":"10.1016\/j.jaut.2017.05.004_bib159","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/bib\/bbv056","article-title":"Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR","volume":"17","author":"Marabita","year":"2016","journal-title":"Brief. Bioinform"},{"key":"10.1016\/j.jaut.2017.05.004_bib160","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrg3198","article-title":"MicroRNA profiling: approaches and considerations","volume":"13","author":"Pritchard","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jaut.2017.05.004_bib161","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2230.2012.04453.x","article-title":"The miR-146a rs2910164 C\/G polymorphism is associated with telangiectasia in systemic sclerosis","volume":"38","author":"Sakoguchi","year":"2013","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib162","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1128\/MCB.25.11.4727-4741.2005","article-title":"5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal","volume":"25","author":"Ghoshal","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jaut.2017.05.004_bib163","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/npp.2013.207","article-title":"Antidepressant-like properties of novel HDAC6-selective inhibitors with improved brain bioavailability","volume":"39","author":"Jochems","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jaut.2017.05.004_bib164","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1440-1843.2012.02284.x","article-title":"Sirtuin 1 activator SRT1720 suppresses inflammation in an ovalbumin-induced mouse model of asthma","volume":"18","author":"Ichikawa","year":"2013","journal-title":"Respirology"},{"key":"10.1016\/j.jaut.2017.05.004_bib165","doi-asserted-by":"crossref","first-page":"e51395","DOI":"10.1371\/journal.pone.0051395","article-title":"A\u00a0pilot randomized, placebo controlled, double blind phase I trial of the novel SIRT1 activator SRT2104 in elderly volunteers","volume":"7","author":"Libri","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2017.05.004_bib166","first-page":"e620","article-title":"Bromodomain inhibitor review: bromodomain and extra-terminal family protein inhibitors as a potential new therapy in central nervous system tumors","volume":"8","author":"Wadhwa","year":"2016","journal-title":"Cureus"},{"key":"10.1016\/j.jaut.2017.05.004_bib167","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ddtec.2016.06.004","article-title":"Clinical trials for BET inhibitors run ahead of the science","volume":"19","author":"Andrieu","year":"2016","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.jaut.2017.05.004_bib168","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature14248","article-title":"Integrative analysis of 111 reference human epigenomes","volume":"518","author":"Roadmap Epigenomics","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2017.05.004_bib169","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.tcb.2014.08.010","article-title":"Epigenetics reloaded: the single-cell revolution","volume":"24","author":"Bheda","year":"2014","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jaut.2017.05.004_bib170","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1093\/nar\/gkt072","article-title":"Global profiling of miRNAs and the hairpin precursors: insights into miRNA processing and novel miRNA discovery","volume":"41","author":"Li","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jaut.2017.05.004_bib171","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/nar\/gkt1021","article-title":"Biases in small RNA deep sequencing data","volume":"42","author":"Raabe","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jaut.2017.05.004_bib172","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/art.24600","article-title":"Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population","volume":"60","author":"Ito","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib173","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3899\/jrheum.091163","article-title":"Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity","volume":"37","author":"Dieude","year":"2010","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib174","doi-asserted-by":"crossref","first-page":"e54419","DOI":"10.1371\/journal.pone.0054419","article-title":"The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis","volume":"8","author":"Carmona","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2017.05.004_bib175","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/hmg\/ddu455","article-title":"The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share","volume":"24","author":"Kottyan","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jaut.2017.05.004_bib176","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/annrheumdis-2011-200275","article-title":"Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis","volume":"71","author":"Carmona","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.004_bib177","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13075-015-0572-y","article-title":"Identification of NF-kappaB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis","volume":"17","author":"Arismendi","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2017.05.004_bib178","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/art.37777","article-title":"PLD4 as a novel susceptibility gene for systemic sclerosis in a Japanese population","volume":"65","author":"Terao","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib179","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1136\/ard.2010.147009","article-title":"Independent replication establishes the CD247 gene as a genetic systemic sclerosis susceptibility factor","volume":"70","author":"Dieude","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.004_bib180","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1136\/ard.2009.127928","article-title":"Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population","volume":"69","author":"Dieude","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.004_bib181","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1093\/hmg\/dds099","article-title":"Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up","volume":"21","author":"Martin","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jaut.2017.05.004_bib182","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1002\/art.34490","article-title":"Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity","volume":"64","author":"Koumakis","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib183","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/ard.2009.116434","article-title":"Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis","volume":"69","author":"Gourh","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.004_bib184","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/ard.2010.141838","article-title":"A\u00a0replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort","volume":"70","author":"Bossini-Castillo","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.004_bib185","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3899\/jrheum.111270","article-title":"Independent replication and meta analysis of association studies establish TNFSF4 as a susceptibility gene preferentially associated with the subset of anticentromere-positive patients with systemic sclerosis","volume":"39","author":"Coustet","year":"2012","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib186","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/ard.2010.130138","article-title":"Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis","volume":"70","author":"Diaz-Gallo","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.004_bib187","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/art.23601","article-title":"The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis","volume":"58","author":"Dieude","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib188","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1002\/art.22196","article-title":"Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis","volume":"54","author":"Gourh","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.05.004_bib189","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1007\/s11033-011-1074-x","article-title":"The association between the PTPN22 C1858T polymorphism and systemic sclerosis: a meta-analysis","volume":"39","author":"Lee","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jaut.2017.05.004_bib190","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1136\/annrheumdis-2015-208154","article-title":"Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathway","volume":"75","author":"Lopez-Isac","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2017.05.004_bib191","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1002\/art.38870","article-title":"Identification of IL12RB1 as a novel systemic sclerosis susceptibility locus","volume":"66","author":"Lopez-Isac","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib192","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/hmg\/ddr522","article-title":"A\u00a0GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations","volume":"21","author":"Bossini-Castillo","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jaut.2017.05.004_bib193","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/exd.12245","article-title":"Hair miR-29a levels are decreased in patients with scleroderma","volume":"22","author":"Takemoto","year":"2013","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jaut.2017.05.004_bib194","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/08916934.2015.1030616","article-title":"MicroRNA-29a induces apoptosis via increasing the Bax:Bcl-2 ratio in dermal fibroblasts of patients with systemic sclerosis","volume":"48","author":"Jafarinejad-Farsangi","year":"2015","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2017.05.004_bib195","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jdermsci.2013.06.018","article-title":"Detection of hair-microRNAs as the novel potent biomarker: evaluation of the usefulness for the diagnosis of scleroderma","volume":"72","author":"Wang","year":"2013","journal-title":"J.\u00a0Dermatol. Sci."},{"key":"10.1016\/j.jaut.2017.05.004_bib196","doi-asserted-by":"crossref","unstructured":"Urban JR, King B. Divalproex sodium: A potential therapy for scleroderma digital ulcers. JAAD Case Reports;1:44\u201345.","DOI":"10.1016\/j.jdcr.2014.11.004"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841117303256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841117303256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:16:52Z","timestamp":1760257012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841117303256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":196,"alternative-id":["S0896841117303256"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2017.05.004","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unfolding the pathogenesis of scleroderma through genomics and epigenomics","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2017.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}